JP2018526447A5 - - Google Patents

Download PDF

Info

Publication number
JP2018526447A5
JP2018526447A5 JP2018530940A JP2018530940A JP2018526447A5 JP 2018526447 A5 JP2018526447 A5 JP 2018526447A5 JP 2018530940 A JP2018530940 A JP 2018530940A JP 2018530940 A JP2018530940 A JP 2018530940A JP 2018526447 A5 JP2018526447 A5 JP 2018526447A5
Authority
JP
Japan
Prior art keywords
composition
molecular weight
high molecular
conditioned medium
weight complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018530940A
Other languages
English (en)
Japanese (ja)
Other versions
JP6995752B2 (ja
JP2018526447A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2016/000316 external-priority patent/WO2017041133A1/en
Publication of JP2018526447A publication Critical patent/JP2018526447A/ja
Publication of JP2018526447A5 publication Critical patent/JP2018526447A5/ja
Priority to JP2021203331A priority Critical patent/JP2022027928A/ja
Application granted granted Critical
Publication of JP6995752B2 publication Critical patent/JP6995752B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018530940A 2015-09-08 2016-09-08 細胞拡大培養方法及び治療用組成物 Expired - Fee Related JP6995752B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021203331A JP2022027928A (ja) 2015-09-08 2021-12-15 細胞拡大培養方法及び治療用組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2015903658A AU2015903658A0 (en) 2015-09-08 Cell expansion methods and therapeutic compositions
AU2015903658 2015-09-08
PCT/AU2016/000316 WO2017041133A1 (en) 2015-09-08 2016-09-08 Cell expansion methods and therapeutic compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021203331A Division JP2022027928A (ja) 2015-09-08 2021-12-15 細胞拡大培養方法及び治療用組成物

Publications (3)

Publication Number Publication Date
JP2018526447A JP2018526447A (ja) 2018-09-13
JP2018526447A5 true JP2018526447A5 (enExample) 2019-10-24
JP6995752B2 JP6995752B2 (ja) 2022-02-04

Family

ID=58240422

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018530940A Expired - Fee Related JP6995752B2 (ja) 2015-09-08 2016-09-08 細胞拡大培養方法及び治療用組成物
JP2021203331A Pending JP2022027928A (ja) 2015-09-08 2021-12-15 細胞拡大培養方法及び治療用組成物
JP2022172508A Pending JP2022186992A (ja) 2015-09-08 2022-10-27 細胞拡大培養方法及び治療用組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021203331A Pending JP2022027928A (ja) 2015-09-08 2021-12-15 細胞拡大培養方法及び治療用組成物
JP2022172508A Pending JP2022186992A (ja) 2015-09-08 2022-10-27 細胞拡大培養方法及び治療用組成物

Country Status (10)

Country Link
US (2) US20180236003A1 (enExample)
EP (1) EP3347449A4 (enExample)
JP (3) JP6995752B2 (enExample)
KR (1) KR20180043834A (enExample)
CN (1) CN108348555B (enExample)
AU (1) AU2016321448B2 (enExample)
CA (1) CA3035931A1 (enExample)
HK (1) HK1252778A1 (enExample)
TW (1) TWI760313B (enExample)
WO (1) WO2017041133A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016342387B2 (en) * 2015-10-23 2021-12-09 Rigshospitalet Stem cell therapy based on adipose-derived stem cells
WO2018213795A1 (en) * 2017-05-18 2018-11-22 The Board Of Trustees Of The Leland Stanford Junior University Targeted in situ therapeutic delivery of secreted factors from stem cells for treatment of damaged tissue
CA3103043A1 (en) 2018-06-15 2019-12-19 Luis Marinas Pardo Pharmaceutical composition for dermatology and uses thereof
CN109022360A (zh) * 2018-07-03 2018-12-18 湖南未名三胞转化医学科技有限公司 自体脂肪干细胞共培养促进外周血造血干细胞增殖方法
CN110106142B (zh) * 2019-05-30 2020-05-12 深圳阿尔法生物科技有限公司 一种制备“百亿”级脂肪源再生细胞的生产工艺
CN111073857A (zh) * 2019-12-30 2020-04-28 深圳爱生再生医学科技有限公司 一种治疗关节炎的干细胞生物制品及其制备方法与应用
KR102193175B1 (ko) * 2020-04-07 2020-12-18 주식회사 엑소스템텍 통증조절인자를 함유한 줄기세포유래 엑소좀 및 그 용도
CO2020012570A1 (es) 2020-10-08 2022-04-08 Inst Distrital De Ciencia Biotecnologia E Innovacion En Salud Idcbis Método de estimulación de células mesenquimales para inducir expresión de factores inmunomoduladores
US20230365937A1 (en) * 2020-10-26 2023-11-16 Hadasit Medical Research Services And Development Ltd. Mesenchymal stem cells and their culture
BR102022016233A2 (pt) * 2022-08-16 2024-02-27 Omics Biotecnologia Animal Ltda Concentrado de proteínas e peptídeos derivados de células estromais mesenquimais, método de obtenção e uso de concentrado

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0404656D0 (en) * 2004-03-02 2004-04-07 Univ Manchester Treatment of spinal conditions
WO2008034803A1 (en) * 2006-09-18 2008-03-27 Medizinische Universität Graz Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics
PL2611906T3 (pl) * 2010-08-31 2024-05-27 Gallant Pet, Inc. Ogólnoustrojowe terapie allogenicznymi komórkami macierzystymi do leczenia chorób u kotów i psów
SG10201606745XA (en) 2011-09-23 2016-10-28 Cell Ideas Pty Ltd Therapeutics using adipose cells and cell secretions
US20140219972A1 (en) * 2013-02-05 2014-08-07 The Board Of Trustees Of The Leland Stanford Junior University Tissue engineering using progenitor cells to catalyze tissue formation by primary cells
EP3405204B1 (en) * 2016-08-26 2025-06-25 Restem Llc Composition and methods of using umbilical cord lining stem cells

Similar Documents

Publication Publication Date Title
JP2018526447A5 (enExample)
SG10201903474PA (en) New substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs
JP2013177430A5 (enExample)
JP2017519723A5 (enExample)
HRP20240798T1 (hr) Terapija matičnim stanicama kod patologija endometrija
JP2013507945A5 (enExample)
Wu et al. c73 new mechanisms and therapies in copd: activating transcription factor 3 represses cigarette smoke-induced il6 and il8 expression via suppressing nuclear factor-κb (nf-κb) activation
JP2016518415A5 (enExample)
YANG et al. Effect of paroxetine combined with low dose of olanzapine on sleep process and architecture of depression patients with insomnia
MENG et al. Influence of psychological nursing intervention on the pain, sleep quality and life quality of patients with gastric cancer
CHEN Efficacy of oral montelukast combined with budesonide suspension inhalation in the treatment of children with cough variant asthma and its effect on inflammatory cytokines
YU Latest research topics on allergic asthma
CN206822393U (zh) 具有保健功能的弹簧床芯用支撑力可调弹簧组
CN105770384A (zh) 一种药物组合物提取物及其用途
CHENG et al. Comprehensive Optimization of Rehabilitation Measures of Traditional Chinese Medicine to Elderly Patients with COPD at Stable Period
PAN et al. The effects of Xuebijing injection on immune function of patients with acute exacerbation of chronic obstructive pulmonary disease
Min-Ji et al. Immune-enhancing activity of Sargassum hemiphyllum water extract
TONG et al. Role of Th1 cell and its related cytokines IFN-γin the regulation of immune function in patients with AIDS
XIE et al. Application of deferred stent implantation in patients with high thrombus burden of acute ST-segment ele-vation myocardial infarction
Dewhurst et al. C34 INSIGHTS INTO COPD PATHOGENESIS FROM PRE-CLINICAL STUDIES: Characterising Subpopulations Of Alveolar And Interstitial Macrophages In Chronic Obstructive Pulmonary Disease
Jiang et al. Changes of CD4+ CD25+ Foxp3+ regulatory T cells in different stages of COPD and intervention of Qibai Pingfei Capsules
Schlaich et al. P2y14 receptor deficiency attenuates phenotype of allergic airway inflammation in mice
LIU The relation between chemokines and retinal vein occlusion
Schlaich et al. D101 ALLERGY AND ASTHMA: NOVEL REGULATORY PATHWAYS: P2y14 Receptor Deficiency Attenuates Phenotype Of Allergic Airway Inflammation In Mice
Kroll et al. Risk Mitigation for Hematopoietic Progenitor Cell Infusion-Related Toxicity in Autologous Stem Cell Transplant Recipients